Multidimensional evidence generation and FDA regulatory decision making: Defining and using “real-world” data

JAMA - Journal of the American Medical Association

Volumn 318, Issue 8, 2017, Pages 703-704

  Jarow, Jonathan P ^a   Lavange, Lisa ^a   Woodcock, Janet ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEHAVIOR; BIOMEDICINE; CLINICAL DECISION MAKING; CLINICAL PRACTICE; DATA ANALYSIS; ELECTRONIC MEDICAL RECORD; EVIDENCE BASED MEDICINE; FOOD AND DRUG ADMINISTRATION; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH SURVEY; HUMAN; MEDICAL RESEARCH; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REAL WORLD DATA; REAL WORLD EVIDENCE; SAFETY; SHORT SURVEY; SIMULATION; UNITED STATES; CLINICAL TRIAL (TOPIC); DECISION MAKING; EVIDENCE BASED PRACTICE; GOVERNMENT REGULATION; INFORMATION PROCESSING;

CLINICAL TRIALS AS TOPIC; DATASETS AS TOPIC; DECISION MAKING; EVIDENCE-BASED PRACTICE; GOVERNMENT REGULATION; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 85028364581     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2017.9991     Document Type: Short Survey

References (8)

1. Sung NS, Crowley WF Jr, Genel M, et al. Central challenges facing the National Clinical Research Enterprise. JAMA. 2003;289(10):1278-1287.
2. Fröbert O, Lagerqvist B, Olivecrona GK, et al; TASTE Trial. Thrombus aspiration during ST-segment elevation myocardial infarction. N Engl J Med. 2013;369(17):1587-1597.
3. Feinstein AR. The Architecture of Clinical Research. Philadelphia, PA: WB Saunders Co; 1985.
4. Benjamin EJ, Levy D, Vaziri SM, D’Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study. JAMA. 1994;271(11):840-844.
5. Thorpe KE, Zwarenstein M, Oxman AD, et al. A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. J Clin Epidemiol. 2009;62(5):464-475.
6. Anglemyer A, Horvath HT, Bero L. Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials. Cochrane Database Syst Rev. 2014;(4):MR000034.
7. 21st Century Cures Act, HR 34, 114th Cong, 2nd Sess (2016).
8. Sasinowski FJ, Panico EB, Valentine JE. Quantum of effectiveness evidence in FDA’s approval of orphan drugs: update, July 2010 to June 2014. Ther Innov Regul Sci. 2015;49:680-697. doi:10.1177 /2168479015580383